who discovered glp 1 drugs Joel Habener, Whose Research Led to Weight-Loss Drugs, Dies at 88 The Future of GLP-1 Drugs

G., Wang, Z., Zhu, W., Gupta, N., Skye, S

Central Illustration Abstract Background Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have demonstrated significant cardiovascular (CV) benefits, particularly in patients with diabetes mellitus, but the safety and efficacy of different GLP-1 RAs across diverse populations remain insufficiently defined

Anisimov VN, Khavinson VK, Popovich IG, Zabezhinski MA, Alimova IN, Rosenfeld SV, Baturin DA, Semenchenko AV, Yashin AI

Autism There is increasing evidence that glutathione levels in autistic individuals are lower, which could be due to the increase in oxidative damage and inflammation

2014 Jun 1;20(16):2606-20